Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F; CLETRAT Investigators. Ramacciotti E, et al. Thromb Res. 2004;114(3):149-53. doi: 10.1016/j.thromres.2004.05.009. Thromb Res. 2004. PMID: 15342210 Clinical Trial.
Contaminant in the recalled unfractionated heparin preparations: where is the problem?
Hoppensteadt DA, Wahi R, Adiguzel C, Iqbal O, Ramacciotti E, Bick RL, Messmore HL, Bansal V, Fareed J. Hoppensteadt DA, et al. Among authors: ramacciotti e. Clin Appl Thromb Hemost. 2008 Jul;14(3):261-6. doi: 10.1177/1076029608317932. Epub 2008 Jun 19. Clin Appl Thromb Hemost. 2008. PMID: 18565985 Free article. No abstract available.
Contaminants in heparins: are all facts known?
Fareed J, Hoppensteadt DA, Ramacciotti E, Hull RD. Fareed J, et al. Among authors: ramacciotti e. Clin Appl Thromb Hemost. 2010 Jun;16(3):242-3. doi: 10.1177/1076029610365507. Clin Appl Thromb Hemost. 2010. PMID: 20547552 Free article. No abstract available.
[Concerns on generic enoxaparin use in acute coronary syndrome].
Gomes M, Ramacciotti E, Litinas E, Fareed J. Gomes M, et al. Among authors: ramacciotti e. Arq Bras Cardiol. 2010 Oct;95(4):551-2. doi: 10.1590/s0066-782x2010001400022. Arq Bras Cardiol. 2010. PMID: 21180789 Free article. Multiple languages. No abstract available.
Generic versus branded enoxaparin in the prevention of venous thromboembolism following major abdominal surgery: report of an exploratory clinical trial.
Gomes M, Ramacciotti E, Henriques AC, Araujo GR, Szultan LA, Miranda F Jr, Thethi I. Gomes M, et al. Among authors: ramacciotti e. Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):633-9. doi: 10.1177/1076029611418967. Epub 2011 Sep 23. Clin Appl Thromb Hemost. 2011. PMID: 21949036 Free article. Clinical Trial.
Enoxaparin Treatment Followed by Rivaroxaban for the Treatment of Acute Lower Limb Venous Thromboembolism: Initial Experience in a Single Center.
Wolosker N, Varella AY, Fukuda JM, Teivelis M, Kuzniec S, Krutman M, Guerra JC, Ramacciotti E. Wolosker N, et al. Among authors: ramacciotti e. Clin Appl Thromb Hemost. 2016 May;22(4):377-80. doi: 10.1177/1076029615621999. Epub 2016 Jan 5. Clin Appl Thromb Hemost. 2016. PMID: 26739543 Free article. Clinical Trial.
97 results